Cargando…

The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance

Interleukin-8 (IL-8, CXCL8) is a pro-inflammatory chemokine produced by various cell types to recruit leukocytes to sites of infection or tissue injury. Acquisition of IL-8 and/or its receptors CXCR1 and CXCR2 are known to be a relatively common occurrence during tumor progression. Emerging research...

Descripción completa

Detalles Bibliográficos
Autores principales:	David, Justin M., Dominguez, Charli, Hamilton, Duane H., Palena, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041016/ https://www.ncbi.nlm.nih.gov/pubmed/27348007 http://dx.doi.org/10.3390/vaccines4030022

Ejemplares similares

IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
por: Fernando, Romaine I., et al.
Publicado: (2016)

Upregulation of oncogenic MUC1 by the EMT transcription factor brachyury mediates immunotherapy-resistance in tumor cells
por: David, Justin M, et al.
Publicado: (2015)

MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition
por: David, Justin M., et al.
Publicado: (2016)

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
por: Bilusic, Marijo, et al.
Publicado: (2019)

Hsp60 and IL-8 axis promotes apoptosis resistance in cancer
por: Kumar, Sandeep, et al.
Publicado: (2019)

Interleukin-8 drives epithelial-mesenchymal transition of human carcinomas
por: Fernando, Romaine I, et al.
Publicado: (2013)

Regulatory Role of IL-1R8 in Immunity and Disease
por: Molgora, Martina, et al.
Publicado: (2016)

Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack
por: Hamilton, Duane H., et al.
Publicado: (2018)

The IL‐27/IL‐27R axis is altered in CD4(+) and CD8(+) T lymphocytes from multiple sclerosis patients
por: Clénet, Marie‐Laure, et al.
Publicado: (2021)

Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies
por: Dominguez, Charli, et al.
Publicado: (2016)

The role of oncogenic MUC1-C in brachyury-induced immunotherapy resistance
por: David, Justin, et al.
Publicado: (2014)

Expression and significance of IL-6 and IL-8 in canine mammary gland tumors
por: Ren, Xiaoli, et al.
Publicado: (2023)

Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease
por: Supino, Domenico, et al.
Publicado: (2022)

High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity
por: Campesato, Luis Felipe, et al.
Publicado: (2017)

Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria
por: Papadopoulos, Jordan, et al.
Publicado: (2014)

The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma
por: Stronach, Euan A., et al.
Publicado: (2015)

Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation
por: Sirota, Jeffrey C, et al.
Publicado: (2013)

Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis
por: Bergantini, Laura, et al.
Publicado: (2022)

Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response
por: Krupa, Agnieszka, et al.
Publicado: (2015)

Interleukin 8 (IL-8) - a universal biomarker?
por: Shahzad, Aamir, et al.
Publicado: (2010)

IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections.
por: Basso, Beatriz, et al.
Publicado: (2005)

IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8
por: Sánchez-Fernández, Alba, et al.
Publicado: (2021)

Brachyury, a driver of tumor invasiveness and resistance to multiple therapies, is a novel immunotherapy target
por: Palena, Claudia, et al.
Publicado: (2013)

IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases
por: Murdaca, Giuseppe, et al.
Publicado: (2019)

The IL-33/IL-31 Axis in Allergic and Immune-Mediated Diseases
por: Murdaca, Giuseppe, et al.
Publicado: (2023)

Targeting the IL-12/IL-23 axis: An alternative approach to removing tumor induced immune suppression
por: Smyth, Mark J, et al.
Publicado: (2014)

The role of cytokines in seizures: interleukin (IL)-1β, IL-1Ra, IL-8, and IL-10
por: Youn, Youngah, et al.
Publicado: (2013)

Selective costimulation by IL-15R/IL-15, but not IL-2R/IL-2, allows the induction of high numbers of tumor-specific CD8+ T cells by human dendritic cells matured in conditions of acute inflammation
por: Hansen, Morten, et al.
Publicado: (2015)

Effects of ulinastatin and docataxel on breast tumor growth and expression of IL-6, IL-8, and TNF-α
por: Zhao, Xiaoliang, et al.
Publicado: (2011)

Discovery of IL-8/CXCL8 (The Story from Frederick)
por: Yoshimura, Teizo
Publicado: (2015)

Chemical makeover inhibits IL-8
por: Bashyam, Hema
Publicado: (2008)

Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
por: Bester, Janette, et al.
Publicado: (2016)

Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
por: Feng, Lanyun, et al.
Publicado: (2018)

Impact of Chronic Rhinosinusitis with Nasal Polyposis on IL-12 and IL-8
por: do Amaral, Janatas Bussador, et al.
Publicado: (2023)

IL-6 and IL-8: An Overview of Their Roles in Healthy and Pathological Pregnancies
por: Vilotić, Aleksandra, et al.
Publicado: (2022)

Aplastic anemia severity and IL-6 and IL-8 blood levels
por: Bhargawa, Sharvan Kumar, et al.
Publicado: (2022)

Expression of IL-8, IL-6 and IL-1β in Tears as a Main Characteristic of the Immune Response in Human Microbial Keratitis
por: Santacruz, Concepcion, et al.
Publicado: (2015)

Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB
por: Sun, Shan, et al.
Publicado: (2010)

IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells
por: Landolina, Nadine, et al.
Publicado: (2022)

An immunotherapeutic intervention against tumor progression: Targeting a driver of the epithelial-to-mesenchymal transition
por: Palena, Claudia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l4s4hlgipiqjm4dk8va63etmgs